Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision medication model for paclitaxel + cisplatin in non-small cell lung cancer
ChiCTR2000040783Phase 4Completed
- Sponsor
- Cancer Hospital, Chinese Academy of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel and cisplatin in non-small cell lung cancer (NSCLC), sponsored by Cancer Hospital, Chinese Academy of Medical Sciences. Primary endpoints: toxicity and response evaluation. Started Jan 2017; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2000040783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040783.